- Conditions
- Progressive Metastatic Malignancies
- Interventions
- ALT-801
- Biological
- Lead sponsor
- Altor BioScience
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 26 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 4
- States / cities
- Aurora, Colorado • Orlando, Florida • Tampa, Florida + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 409–432
of 1,228
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Adolescent Idiopathic Scoliosis, Posterior Spinal Fusion
- Interventions
- Not listed
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 10 Years to 18 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
- Conditions
- Degenerative Disc Disease (DDD)
- Interventions
- Lumbar Interbody Fusion Devices
- Device
- Lead sponsor
- Spine and Scoliosis Research Associates
- Other
- Eligibility
- 18 Years to 110 Years
- Enrollment
- 465 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 4
- States / cities
- San Francisco, California • New York, New York • Charlotte, North Carolina + 1 more
- Conditions
- HIV Infections
- Interventions
- Enfuvirtide-intensified HAART
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2009
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Degenerative Disc Disease
- Interventions
- Fortilink IBF System with TETRAfuse Technology
- Device
- Lead sponsor
- Xtant Medical
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 14
- States / cities
- Sherman Oaks, California • Lone Tree, Colorado • Boca Raton, Florida + 11 more
- Conditions
- Ewing Sarcoma, Desmoplastic Small Round Cell Tumor
- Interventions
- EWSR1 immunotherapy, Pembrolizumab
- Drug
- Lead sponsor
- Rabi Hanna
- Other
- Eligibility
- 2 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- HIV Infections
- Interventions
- CD4-IgG
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 2
- States / cities
- Stanford, California • Seattle, Washington
- Conditions
- Degenerative Disc Disease, Spinal Stenosis
- Interventions
- OssDsign® Catalyst
- Device
- Lead sponsor
- OssDsign
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 450 participants
- Timeline
- 2022 – 2030
- U.S. locations
- 15
- States / cities
- Fresno, California • Long Beach, California • San Diego, California + 12 more
- Conditions
- Graft vs Host Disease
- Interventions
- Rituximab, Prednisone, Cyclosporine A, tacrolimus
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 1 Year to 75 Years
- Enrollment
- 37 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2014
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Metastatic Prostate Cancer
- Interventions
- sipuleucel-T, enzalutamide
- Biological · Drug
- Lead sponsor
- Dendreon
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 19
- States / cities
- Tucson, Arizona • Los Angeles, California • Denver, Colorado + 16 more
- Conditions
- Acute Myelogenous Leukemia, AML
- Interventions
- DC AML Vaccine
- Biological
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 63 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2025
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Hypophosphatasia (HPP)
- Interventions
- Asfotase Alfa
- Biological
- Lead sponsor
- Alexion Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 2
- States / cities
- St Louis, Missouri • Durham, North Carolina
- Conditions
- Cervical Stenosis, Myelopathy, Cervical Spondylosis With Myelopathy, Degenerative Disc Disease, Radiculopathy
- Interventions
- Primary Anterior Cervical Discectomy Procedures
- Procedure
- Lead sponsor
- Hospital for Special Surgery, New York
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 76 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Lupus Nephritis
- Interventions
- Atacicept, Mycophenolate mofetil, Placebo, Corticosteroids
- Drug
- Lead sponsor
- EMD Serono
- Industry
- Eligibility
- 16 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 12
- States / cities
- New Orleans, Louisiana • Shreveport, Louisiana • Detroit, Michigan + 9 more
- Conditions
- Prostate Cancer
- Interventions
- Standard of Care Biopsy
- Procedure
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 18 Years to 99 Years · Male only
- Enrollment
- 29 participants
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Tobacco Use
- Interventions
- e-Vapor Product A, e-Vapor Product B, e-Vapor Product C, e-Vapor Product D
- Other
- Lead sponsor
- Altria Client Services LLC
- Industry
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 35 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- High Point, North Carolina
- Conditions
- Prostate Cancer
- Interventions
- Focal-Fusion Bx
- Device
- Lead sponsor
- Focal Healthcare Inc.
- Industry
- Eligibility
- 18 Years to 80 Years · Male only
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Sarasota, Florida
- Conditions
- SLE (Systemic Lupus), RA - Rheumatoid Arthritis
- Interventions
- NTR1011
- Drug
- Lead sponsor
- Neutrolis
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 7
- States / cities
- Apple Valley, California • Beverly Hills, California • Covina, California + 4 more
- Conditions
- Sacroiliac Joint Dysfunction, Sacroiliac; Fusion, Sacroiliac Disorder, Sacroiliac Joint Pain
- Interventions
- Use of iFuse TORQ
- Device
- Lead sponsor
- SI-BONE, Inc.
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 110 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 14
- States / cities
- Napa, California • Santa Monica, California • Shelbyville, Indiana + 11 more
- Conditions
- Friedreich Ataxia
- Interventions
- Nomlabofusp, Placebo
- Drug
- Lead sponsor
- Larimar Therapeutics, Inc.
- Industry
- Eligibility
- 2 Years to 17 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Chevy Chase, Maryland
- Conditions
- Solid Tumor, Hematologic Malignancies
- Interventions
- BGJ398
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 84 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 56
- States / cities
- Birmingham, Alabama • Oceanside, California • San Francisco, California + 49 more
- Conditions
- Heart Failure With Reduced Ejection Fraction
- Interventions
- JK07, Matching Placebo
- Drug
- Lead sponsor
- Salubris Biotherapeutics Inc
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 7
- States / cities
- Tucson, Arizona • Stanford, California • Boston, Massachusetts + 4 more
- Conditions
- Lymphoma
- Interventions
- Alefacept
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 120 Years
- Enrollment
- 23 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2019
- U.S. locations
- 3
- States / cities
- Duarte, California • Iowa City, Iowa • Rochester, Minnesota
- Conditions
- Sacroiliac Joint Disruption, Degenerative Sacroiliitis
- Interventions
- Pelvic CT Scan
- Radiation
- Lead sponsor
- Tenon Medical
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 2
- States / cities
- Plano, Texas • St. George, Utah